Effects of High Intensity Interval Training and Combined Training in Type 2 Diabetic (T2D) Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
Diabetes has become a widespread epidemic, primarily because of the increasing prevalence and incidence of type 2 diabetes (T2D). T2D is a significant cause of premature mortality and morbidity related to cardiovascular disease, blindness, kidney and nerve disease, and amputation. Physical activity improves blood glucose control and can prevent or delay T2D, along with positively affecting lipids, blood pressure, cardiovascular events, mortality, and quality of life. At present, although physical activity is a key element in the prevention and management of T2D, the most effective exercise strategy (intensity, duration, and type of exercise) for improving glucose control and reducing cardiometabolic risk in type 2 diabetes has not been defined. Studies with Light-Emitting Diode (LED) therapy have demonstrated its ability to promote pain relief, improve muscle and cardiopulmonary performance, minimize muscle fatigue, and stimulate wound healing. In relation to patients with T2D, who have prolonged conditions of hyperglycemia, studies to investigate the impact of photobiomodulation associated with physical training have not been found so far. The objective of this study is to investigate the effects of different types of physical training associated with Light-Emitting Diode (LED) therapy on cardiometabolic status and quality of life in patients with T2D.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus-type-2
Started Aug 2020
Typical duration for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2018
CompletedFirst Posted
Study publicly available on registry
July 20, 2018
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedMay 17, 2022
May 1, 2022
2 months
May 7, 2018
May 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Functional exercise capacity
Oxygen consumption measurement during cardiopulmonary test
Change from Baseline to 12 weeks
Incremental shuttle walking test
Distance in meters
Change from Baseline to 12 weeks
Glycemic control
Evaluated by the percentage of glycated hemoglobin
Change from Baseline to 12 weeks
Secondary Outcomes (7)
Autonomic Nervous System
Change from Baseline to 12 weeks
Musculoskeletal Function
Change from Baseline to 12 weeks
Physical Activity Questionnaire
Change from Baseline to 12 weeks
Endothelial Function
Change from Baseline to 12 weeks
Quality of Life Questionary
Change from Baseline to 12 weeks
- +2 more secondary outcomes
Study Arms (4)
HIIT and LED therapy
EXPERIMENTALLight-Emitting Diode (LED) therapy followed by physical training with high intensity interval training (HIIT)
High intensity interval training (HIIT)
SHAM COMPARATORLight-Emitting Diode (LED) therapy simulation followed by physical training with high intensity interval training (HIIT)
Combined training and LED therapy
EXPERIMENTALLight-Emitting Diode (LED) therapy followed by physical training with combined training
Combined training
SHAM COMPARATORLight-Emitting Diode (LED) therapy simulation followed by physical training with combined training.
Interventions
Type 2 diabetic patients will be subjected to different types of physical training (high intensity interval training or combined training).
Type 2 diabetic patients will be subjected to Light-Emitting Diode (LED) therapy (active or sham).
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years;
- Confirmed diagnosis of type 2 diabetes;
- Sedentary lifestyle in the last six months, according to the criteria established by the American Heart Association (AHA).
You may not qualify if:
- Confirmed diagnosis of any (1) heart disease; (2) musculoskeletal disorder; (3) respiratory disease; (4) uncontrolled arterial hypertension; (5) peripheral neuropathy or (6) factors that limit the performance of any of the study evaluations and/or training.
- During the study, individuals with a presence of less than 80% in the training sessions will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UNINOVE
São Paulo, São Paulo, 03332010, Brazil
Related Publications (9)
Bassi D, Mendes RG, Arakelian VM, Caruso FC, Cabiddu R, Junior JC, Arena R, Borghi-Silva A. Potential Effects on Cardiorespiratory and Metabolic Status After a Concurrent Strength and Endurance Training Program in Diabetes Patients - a Randomized Controlled Trial. Sports Med Open. 2016 Aug 11;2:31. doi: 10.1186/s40798-016-0052-1. eCollection 2015 Jun.
PMID: 27563535BACKGROUNDBoule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001 Sep 12;286(10):1218-27. doi: 10.1001/jama.286.10.1218.
PMID: 11559268BACKGROUNDKarstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, Solomon TP. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2013 Feb;36(2):228-36. doi: 10.2337/dc12-0658. Epub 2012 Sep 21.
PMID: 23002086BACKGROUNDChen L, Pei JH, Kuang J, Chen HM, Chen Z, Li ZW, Yang HZ. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis. Metabolism. 2015 Feb;64(2):338-47. doi: 10.1016/j.metabol.2014.10.018. Epub 2014 Oct 23.
PMID: 25467842BACKGROUNDMadsen SM, Thorup AC, Overgaard K, Jeppesen PB. High Intensity Interval Training Improves Glycaemic Control and Pancreatic beta Cell Function of Type 2 Diabetes Patients. PLoS One. 2015 Aug 10;10(8):e0133286. doi: 10.1371/journal.pone.0133286. eCollection 2015.
PMID: 26258597BACKGROUNDFrancois ME, Little JP. Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes Spectr. 2015 Jan;28(1):39-44. doi: 10.2337/diaspect.28.1.39.
PMID: 25717277BACKGROUNDMadsen SM, Thorup AC, Overgaard K, Bjerre M, Jeppesen PB. Functional and structural vascular adaptations following 8 weeks of low volume high intensity interval training in lower leg of type 2 diabetes patients and individuals at high risk of metabolic syndrome. Arch Physiol Biochem. 2015;121(5):178-86. doi: 10.3109/13813455.2015.1087033. Epub 2015 Oct 15.
PMID: 26471849BACKGROUNDGibbs BB, Dobrosielski DA, Lima M, Bonekamp S, Stewart KJ, Clark JM. The association of arterial shear and flow-mediated dilation in diabetes. Vasc Med. 2011 Aug;16(4):267-74. doi: 10.1177/1358863X11411361. Epub 2011 Jun 27.
PMID: 21708874BACKGROUNDColberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B; American College of Sports Medicine; American Diabetes Association. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010 Dec;33(12):2692-6. doi: 10.2337/dc10-1548. No abstract available.
PMID: 21115771BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luciana MM Sampaio, Professor
Nove de Julho University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of the postgraduate program in Rehabilitation Sciences
Study Record Dates
First Submitted
May 7, 2018
First Posted
July 20, 2018
Study Start
August 1, 2020
Primary Completion
October 1, 2020
Study Completion
December 1, 2022
Last Updated
May 17, 2022
Record last verified: 2022-05